- Report
- August 2025
- 180 Pages
Global
From €3141EUR$3,545USD£2,717GBP
€3490EUR$3,939USD£3,019GBP
- Report
- February 2025
- 200 Pages
Global
From €3978EUR$4,490USD£3,442GBP
- Report
- June 2025
- 150 Pages
Global
From €3411EUR$3,850USD£2,951GBP
€4297EUR$4,850USD£3,718GBP
- Report
- June 2025
- 150 Pages
Global
From €3411EUR$3,850USD£2,951GBP
€4297EUR$4,850USD£3,718GBP
- Report
- April 2025
- 150 Pages
Global
From €3411EUR$3,850USD£2,951GBP
€4297EUR$4,850USD£3,718GBP
- Report
- July 2025
- 175 Pages
Global
From €3978EUR$4,490USD£3,442GBP
- Report
- April 2025
- 175 Pages
Global
From €3978EUR$4,490USD£3,442GBP
- Report
- April 2025
- 175 Pages
Global
From €3978EUR$4,490USD£3,442GBP
- Report
- April 2025
- 200 Pages
Global
From €3978EUR$4,490USD£3,442GBP
- Report
- March 2025
- 175 Pages
Global
From €3978EUR$4,490USD£3,442GBP
- Report
- February 2025
- 200 Pages
Global
From €3978EUR$4,490USD£3,442GBP
- Report
- August 2025
- 177 Pages
Global
From €5183EUR$5,850USD£4,484GBP
- Report
- August 2025
- 378 Pages
Global
From €5183EUR$5,850USD£4,484GBP
- Report
- August 2025
- 278 Pages
Global
From €5183EUR$5,850USD£4,484GBP
- Report
- August 2025
- 207 Pages
Global
From €5183EUR$5,850USD£4,484GBP
- Report
- August 2025
- 194 Pages
Global
From €5183EUR$5,850USD£4,484GBP
- Report
- August 2025
- 193 Pages
Global
From €5183EUR$5,850USD£4,484GBP
- Drug Pipelines
- April 2025
- 180 Pages
Global
From €2215EUR$2,500USD£1,916GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1772EUR$2,000USD£1,533GBP
- Report
- December 2024
- 30 Pages
Global
From €2436EUR$2,750USD£2,108GBP

The Asthma Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of medications used to treat asthma. Asthma is a chronic respiratory condition that affects the airways, causing difficulty breathing, coughing, and wheezing. Asthma drugs are designed to reduce inflammation in the airways, making it easier for patients to breathe. These drugs can be taken orally, inhaled, or injected, depending on the severity of the condition. Common asthma drugs include corticosteroids, bronchodilators, and leukotriene modifiers.
Some of the major companies in the Asthma Drugs market include GlaxoSmithKline, Merck & Co., Novartis, Pfizer, and Sanofi. These companies are involved in the research, development, and marketing of asthma drugs, as well as the production of generic versions of existing drugs. They also provide support services to patients, such as educational materials and access to specialists. Show Less Read more